Engineered Nanoplatelets for Enhanced Treatment of Multiple Myeloma and Thrombus.

ABSTRACT: A platelet-membrane-coated biomimetic nanocarrier, which can sequentially target the bone microenvironment and myeloma cells to enhance the drug availability at the myeloma site and decrease off-target effects, is developed for inhibiting multiple myeloma growth and simultaneously eradicating thrombus complication.

SUBMITTER: Hu Q 

PROVIDER: S-EPMC5283718 | biostudies-literature | 2016 Nov

REPOSITORIES: biostudies-literature